Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

680C91

SKU: orb1306048

Description

680C91 is a potent and selective TDO inhibitor with a Ki of 51 nM. This compound is a valuable research tool for studying the kynurenine pathway in cancer immunology and neurological disease models, both in vitro and in vivo.

Research Area

Immunology & Inflammation, Neuroscience

Images & Validation

Key Properties

CAS Number163239-22-3
MW238.27
Purity>98%
FormulaC15H11FN2
SMILESFc1ccc2c(\C=C\c3cccnc3)c[nH]c2c1
TargetTryptophan
SolubilitySoluble in DMSO (up to 20 mg/ml) or in Ethanol (up to 10 mg/ml)

Bioactivity

Target IC50
TDO:51 nM(Ki)
In Vivo
Prior administration of 68OC91 inhibits the catabolism of L-[ring-2-14C]-tryptophan and a load dose of tryptophan (100 mg/kg) in vivo. Administration of 68OC91 alone significantly increases brain tryptophan, 5-HIAA and 5-HT. A load dose of tryptophan (100 mg/kg), producing increases in brain tryptophan 4-fold greater than that seen with 68OC91, does not increase brain 5-HIAA and 5-HT to levels greater than those seen with 68OC91 and produces a shorter-lasting increase in these parameters.
In Vitro
68OC91, a potent (Ki = 51 nM) and selective TDO inhibitor, has no inhibitory activity against monoamine oxidase A and B, indoleamine 2,3-dioxygenase (EC 1.13.11.17), 5-HT uptake and 5-HT1A,5-HT1D,5-HT2A and 5-HT2c receptors at a concentration of 10 μM. 68OC91 has no effect on the binding of tryptophan to albumin in plasma and inhibited TDO competitively with respect to its substrate tryptophan. 68OC91 inhibits the catabolism of tryptophan by rat liver cells and rat liver perfused in situ.
Cell Research
Cell lines: rat liver cells. Concentrations: 0.1 μM, 0.5 μM, 2 μM. Incubation Time: 0 min - 120 min. Method: The combined concentration of non-labelled L-tryptophan and the L-[ring-2-14C]-tryptophan used in the assays is 20 μM and is added either with or without 68OC91 at time zero.
Animal Research
Animal Models: Male Wistar rats. Dosages: 15 mg/kg. Administration: Oral gavage

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

680C91, 680C-91, Inhibitor, inhibit, TDO, tryptophan 2,3-dioxygenasetryptophan catabolismAlzheimer's Disease

Similar Products

  • 680C91 [orb1218684]

    >98% (HPLC)

    163239-22-3

    238.26

    C15H11FN2

    50 mg, 100 mg, 200 mg, 500 mg, 1 g, 10 mg, 25 mg, 2 mg, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

680C91 (orb1306048)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 200.00
25 mg
$ 440.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry